DRV protocol

It has two arms; Conventional therapies and Evidence based Healing therapies.   We combine the best of conventional medicine with scientifically supported complementary therapies. We recognize that cancer is a complex disease, and therefore it requires a multi-pronged effort to provide the best chances of attaining a remission, cure or significant extension of life.

The DRV Protocol has been the product of 10 years of research and is based on actual clinical practice and outcomes using such an approach in more than 2000 patients. It has a proven safety record and a high rate of acceptability as evidenced by our long-term patients who continue to be on our follow-up.

DRV protocol uses a combination of both therapies to shrink primary tumors, slow the growth, and eliminate cancer cells that have spread to other parts of the body. It is also designed to diminish the adverse side effects and improve the outcome of cyto-toxic therapies.

In the paradigm of integrative medicine, there is a very important role for conventional therapies, such as surgery, chemotherapy and radiotherapy. Although they can be notorious for undesirable side effects (especially chemotherapy), they are highly valuable in a variety of situations, especially where patients either do not respond to gentler treatments or are simply too overwhelmed by end-organ complications upon presentation to initiate self-healing in time.

The Healing Based Non-Toxic therapies on the other hand protect your normal healthy cells, boost your immune system, and block the angiogenic process that supports cancer growth. They also minimize cancer-induced cachexia while promoting the physical and psychological health of the whole person.

From an integrative perspective, the availability of healing therapies adds many other options which can be offered as an adjuvant to surgery. Chemotherapy and other ‘targeted’ therapies remain an option if such interventions do not yield the desired results. Many patients are beginning to explore such options to maximize their chances of long-term disease control.